Business Wire

BURGER-KING

1.9.2022 16:58:34 CEST | Business Wire | Press release

Share
Burger King® to Grow Iconic Restaurant Brand in Poland with New Master Franchisee McWin

Today, the Burger King brand and McWin have announced a new master franchise and development agreement to grow the brand in Poland, with a commitment to open more than 200 restaurants. McWin, a private investment firm specializing in the foodservice and food technology sectors, will manage the brand in Poland, which is present in the country since 2007, including its existing franchisees, and start operating 20 stores as a result of its acquisition of BK SEE Poland S.A.

"We’re excited to share big news from Poland, where we have announced plans to expand Burger King throughout Poland with McWin as our new Master Franchisee,” said David Shear, President, Burger King International Markets. “We know that guests here love our world-famous flame-grilled flavor and experience our brand their way through personalized digital innovation. We see this project as an important part of a larger plan to expand in Central and Eastern Europe that will allow us to bring our iconic brand featuring our great-tasting food to more guests than ever before.”

Founded in 1954, the Burger King brand is a global fast-food hamburger chain known for its food quality and value and as the only place guests can get the iconic flame-grilled Whopper® sandwich. The Burger King system operates more than 19,000 locations in more than 100 countries worldwide, including 33 countries across Europe.

Led by Henry McGovern, founder of AmRest Holdings SE, one of Europe's leading foodservice companies, and Steven K. Winegar, shareholder and senior executive of Zena Group and founder of Restauravia Grupo Empresarial, McWin is composed of an experienced team of industry and PE veterans with proven operational expertise, an unparalleled food industry network and deal origination capabilities, being the partner of choice for founders, investors, and management teams.

“This is the first investment of our €525 million McWin Restaurant Fund, which we closed a few weeks ago. We are incredibly proud to expand the Burger King brand across Poland, leveraging synergies across the McWin platform. We will be putting special emphasis on improving the brand’s digitalization and sustainability efforts in Poland,” Henry McGovern, founding partner at McWin, said.

“Our more than 150 years of combined experience of successfully operating and scaling iconic brands in the hospitality industry across multiple countries will help us unlock sustainable long-term value for customers, employees, and our communities, and for the Polish economy as a whole. We couldn’t be more excited. This is the beginning of an extremely meaningful chapter for both Burger King and McWin,” Steven K. Winegar, founding partner at McWin, added.

In addition to its delicious food, Burger King is committed to providing diners with a best-in-class guest experience, both in-restaurant and online. New Burger King restaurants will feature Digital Ordering Screens, Mobile Ordering, Table Service, and Delivery, so that guests can conveniently order and enjoy BK food however they prefer.

About Henry McGovern, Steven K. Winegar and McWin

McWin is a private investment firm founded by Henry McGovern and Steven K. Winegar partnering with exceptional founders and CEOs daring sustainable disruption, principally in the food service and food technology sectors.

Henry McGovern is the founder of AmRest Holdings SE, one of Europe’s leading foodservice companies, which under Henry’s leadership grew to more than 2,300 restaurants in 25 countries, with 55,000+ employees. Steven K. Winegar was shareholder and senior executive of Grupo Zena and the founder of Restauravia Grupo Empresarial, Megafood SL and former board member of Telepizza. Between them, they have built or operated 4,200+ restaurants across Europe, the United States and China and have extensive experience investing in food technology and broader disruptive technologies. McWin and funds advised by McWin are currently investors in Gail’s, Vapiano, CookUnity and Dean&David as well as alternative protein companies including BlueNalu, Perfect Day, The Every Company (formerly Clara Foods), Impossible Foods and UPSIDE Foods (formerly Memphis Meats) and leading food technology companies such as Footprint, Oishii and Menu.

About Burger King
Founded in 1954, the Burger King® brand is a global fast-food hamburger chain known for food quality and value as the only place guests can get the iconic flame-grilled Whopper® sandwich. The Burger King® system operates more than 18,700 locations in more than 100 countries. Almost 100 percent of Burger King® restaurants are owned and operated by independent franchisees, many of them family-owned operations that have been in business for decades. To learn more about the Burger King® brand, visit www.bk.com.

About Restaurant Brands International
Restaurant Brands International Inc. is one of the world's largest quick service restaurant companies with over $35 billion in annual system-wide sales and over 29,000 restaurants in more than 100 countries. RBI owns four of the world's most prominent and iconic quick service restaurant brands – TIM HORTONS®, BURGER KING®, POPEYES®, and FIREHOUSE SUBS®. These independently operated brands have been serving their respective guests, franchisees, and communities for decades. Through its Restaurant Brands for Good framework, RBI is improving sustainable outcomes related to its food, the planet, and people and communities.

Forward-Looking Statements
This press release contains certain forward-looking statements and information, which reflect management's current beliefs and expectations regarding future events, initiatives and operating performance and speak only as of the date hereof. These forward-looking statements are not guarantees of future performance and involve a number of risks and uncertainties. These forward-looking statements include, without limitation, statements about our expectations regarding the ability of the Burger King business in Poland to open over 200 restaurants in the coming years, as well as its ability to unlock sustainable long-term value for customers, employees, and communities, and for the Polish economy as a whole and creating a best in class experience, and the ability of Burger King to expand in Central and Eastern Europe. The factors that could cause actual results to differ materially from RBI’s expectations are detailed in filings of RBI with the U.S. Securities and Exchange Commission and with the securities regulatory authorities in Canada, such as its annual and quarterly reports and current reports on Form 8-K and include the following risks: risk related to our ability to successfully implement its domestic and international growth strategy and risks related to its international operations; risks related to our ability to compete domestically and internationally in an intensely competitive industry; global economic or other business conditions that may affect the desire or ability of our customers to purchase our products; our relationship with, and the success of, our franchisees and risks related to our fully franchised business model; and the effectiveness of our marketing and advertising programs and franchisee support of these programs. Other than as required under applicable laws, we do not assume a duty to update these forward-looking statements, whether because of new information, subsequent events or circumstances, change in expectations or otherwise.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220901005605/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release

Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release

About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release

Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break

Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye